BlackRock launches iShares US biotech ETF

TER of 0.35%

Tom Eckett
BlackRock launches US biotech ETF

BlackRock launches US biotech ETF

BlackRock has launched the iShares Nasdaq US Biotechnology UCITS ETF investing directly in biotech and pharmaceutical stocks which are listed on the Nasdaq stock exchange.

Listed on the London Stock Exchange on 23 October, the ETF has a total expense ratio (TER) of 0.35% and will track the Nasdaq Biotechnology index. The index, which has 161 stocks, is calculated using...

To continue reading this article...

Join Investment week

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space

  • Get ahead of regulatory and technological changes affecting fund management

  • Important and breaking news stories selected by the editors delivered straight to your inbox each day

  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts

  • Be the first to hear about our extensive events schedule and awards programmes

Join now


Already an Investment Week


More on ETFs

Former fund manager Neil Woodford

Link invests more into Woodford stock Mafic

Fund now sits at £124.3m

clock 30 November 2021 • 1 min read
Richard Staveley is expected to act as a consultant to Harwood as the trust is wound down

Gresham House Strategic board sets out two-year managed wind-down of trust after collapse of review

B share scheme ‘fairest’ way to return capital to shareholders

clock 29 November 2021 • 2 min read
Saturna and HANetf unveil Islamic-compliant ETF

Saturna Capital and HANetf target sharia-compliant stocks with actively-managed ETF

Incorporates ESG criteria

clock 25 November 2021 • 1 min read